| 靶点: |
O-glycosylation. |
| 体内研究: |
Benzyl-α-GalNAc (1 mg/小鼠;肿瘤注射;每天一次;肿瘤大小达到 50-70 毫米后第 4、6、8 和 10 天3) 增强 5 的抗肿瘤活性-FU 通过抑制小鼠的 O-糖基化。 |
| 参考文献: |
1. Kalra AV, et al. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. Br J Cancer. 2007 Oct 8;97(7):910-8. Epub 2007 Oct 2. 2. Kalra AV, et al. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. Eur J Cancer. 2009 Jan;45(1):164-73. 3. Fan X, et al. Protein O glycosylation regulates activation of hepatic stellate cells. Inflammation. 2013 Dec;36(6):1248-52. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.212 ml |
16.06 ml |
32.12 ml |
| 5 mM |
0.642 ml |
3.212 ml |
6.424 ml |
| 10 mM |
0.321 ml |
1.606 ml |
3.212 ml |
| 50 mM |
0.064 ml |
0.321 ml |
0.642 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |